We also investigated the relationship of the Nrf2/HO-1 pathway with the Ca2+/CaMKII/CREB pathway; ML385, an Nrf2 inhibitor, was used to treat HF mice before NBP administration. The gene discussed is CAMK2G; the disease is hydrops fetalis.